강아지 방광 이행세포암 자주 묻는 질문 Q&A — 보호자가 꼭 알아야 할 핵심

Dog Bladder Transitional Cell Carcinoma FAQ — Key Information Every Pet Owner Should Know

UrinaryQ&AMeongsiljang Veterinary Advisory Board

Bladder transitional cell carcinoma is a common malignant tumor in dogs, and early detection is crucial for successful treatment. We’ve compiled the essential information every pet owner should know in a Q&A format.

What Is Canine Bladder Transitional Cell Carcinoma?

An anatomical image showing a dog with transitional cell carcinoma in the bladder

Canine bladder transitional cell carcinoma is a malignant tumor that develops from the transitional cells lining the bladder, and it is most commonly seen in dogs over the age of eight. - Transitional cell carcinoma: This tumor arises when the cells lining the bladder become malignant. Because it carries a high risk of invasion and metastasis, early detection is crucial. - High-risk cancer: In veterinary medicine, this condition is considered difficult to treat and may have a poor prognosis. - Early diagnosis: Consulting with a veterinarian at the first sign of mild symptoms allows for early confirmation, which significantly improves treatment success rates. - Timing of treatment: The earlier treatment begins, the longer the survival period tends to be, and it also helps prevent complications. For this disease, the owner’s careful observation and proactive response are key.

What Are the Main Causes of This Disease?

While the exact cause of bladder transitional cell carcinoma in dogs remains unknown, several risk factors have been identified. - Genetic predisposition: Certain breeds, such as Scottish Terriers and Shetland Sheepdogs, have a higher reported incidence, suggesting a genetic component. - Chronic irritation and inflammation: Persistent irritation or inflammation of the bladder lining can lead to cumulative cellular damage and subsequent changes. - Malignant transformation of urothelium: Tumors form when transitional cells (urothelial cells) lining the bladder undergo malignant transformation. - Age: The disease is generally reported in middle-aged to senior dogs, with cases commonly seen around 8 years of age. - Individual variation: Susceptibility varies among individual dogs even within the same environment. Because pinpointing a single cause is difficult, regular check-ups for early detection are essential.

An image showing how dogs exposed to a smoking environment can experience bladder-related health issues.

What Are the Main Symptoms?

The main symptoms of canine bladder transitional cell carcinoma include difficulty urinating, blood in the urine, frequent attempts to urinate, and decreased urine output. - Hematuria: This is the most common symptom, characterized by blood in the urine. It is often overlooked in the early stages because it may appear mild. - Dysuria: As the bladder becomes constricted or painful, your dog may struggle to pass urine. - Pollakiuria: Your dog may repeatedly attempt to urinate, but only small amounts of urine are produced. - Pain Response: Your dog may show signs of discomfort during urination, lick its abdomen, or change its sitting posture. - Changes in Daily Behavior: A general decline in health may also occur, including reduced appetite and decreased activity levels. If symptoms persist, consult your veterinarian immediately.

Signs Requiring Immediate Veterinary Visit

If your dog is unable to urinate, shows severe pain during urination, or has persistent blood in the urine, immediate veterinary care is necessary. These symptoms could indicate serious conditions such as urethral obstruction or hydronephrosis/ureteral obstruction. Prompt diagnosis by a veterinarian is crucial, as timely treatment is essential.

How Is It Diagnosed?

Diagnosing canine bladder transitional cell carcinoma accurately requires a combination of several diagnostic tests. - Ultrasound: Non-invasively assesses the size and location of tumors within the bladder. - Cystoscopy: Allows direct visualization of the bladder interior and enables biopsy to determine malignancy. - Urinalysis (Cytology): Detects abnormal changes in transitional cells in the urine, aiding in early detection. - Histopathological Biopsy: Confirms the diagnosis by analyzing tissue samples obtained via cystoscopy. - Advanced Imaging (CT/MRI): Precisely evaluates the extent of tumor invasion and checks for metastasis. A comprehensive approach involving multiple tests is essential for early diagnosis.

A veterinarian performing a cystoscopy on a puppy.

What Are the Treatment Options?

Treatment for canine bladder transitional cell carcinoma varies depending on the tumor’s location, size, and whether it has metastasized. - Surgical treatment: Considered when the tumor is localized; removing or debulking the mass can help extend survival time. However, local recurrence after partial resection is common, so surgery is often performed for debulking and palliation rather than with curative intent. - Radiation therapy: Used when surgery is difficult or as an adjunctive treatment; it can help reduce tumor size, but late complications from pelvic radiation have been reported. - Chemotherapy: Regimens such as piroxicam combined with mitoxantrone or carboplatin have been reported; chemotherapy is administered when the risk of metastasis is high or as an adjuvant treatment after surgery. - Combination therapy: Surgery, radiation, and chemotherapy are combined to enhance treatment efficacy. - Individualized treatment: The veterinarian comprehensively evaluates the patient’s condition to develop an optimal treatment plan. The treatment goals often focus on symptom relief and extending survival time.

A puppy receiving radiation therapy at a veterinary clinic.

What Is the Prognosis and Likelihood of Recurrence?

The prognosis for canine bladder transitional cell carcinoma is closely tied to early diagnosis and timely treatment. - Survival time: Reported outcomes vary widely. One study found a median survival time of approximately 6 months (279–385 days) following total cystectomy. Dogs that underwent debulking surgery lived about 350 days, which is longer than the approximately 207 days observed in dogs that did not have surgery. - Risk of recurrence: Local recurrence has been reported in up to 75% of cases after partial cystectomy, indicating a high risk of recurrence when the tumor invades the bladder wall. - Regular check-ups: Consistent follow-up care through ultrasound and urinalysis is necessary even after surgery. - Risk of metastasis: The cancer can spread to the lungs, lymph nodes, abdominal wall, and other areas, so systemic status must be closely monitored using chest radiographs and other methods. - Maintaining quality of life: It is important to enhance quality of life through pain and nutritional management during treatment. Early management is key to long-term survival.

A puppy receiving a regular check-up with a veterinarian.

Comparison Table of Treatment Methods

Item	Suitable Cases	Success Rate	Side Effects
Surgery	When the tumor is localized	With debulking, median survival about 350 days (about 207 days without surgery); complete resection reports 6 months / 279–385 days	Pain, recovery period, possible local recurrence
Radiation Therapy	When surgery is difficult or as combination therapy	May reduce tumor size and relieve pain	Dermatitis, gastrointestinal symptoms, late complications after pelvic radiation
Chemotherapy	High likelihood of metastasis or as adjuvant after surgery	Reports of piroxicam combined with mitoxantrone/carboplatin	Reduced appetite, blood abnormalities

The treatment method is decided by the veterinarian based on the individual situation.

Key Point: Early Detection Is Crucial

Bladder transitional cell carcinoma often presents with subtle symptoms in its early stages, making it easy for pet owners to overlook. If your pet experiences recurrent blood in the urine or difficulty urinating, seek veterinary evaluation immediately. Early detection significantly improves treatment success rates, so careful monitoring is essential.

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

Can bladder transitional cell carcinoma in dogs be genetic?

Cases have been reported more frequently in certain breeds, such as Scottish Terriers and Shetland Sheepdogs, suggesting a possible genetic predisposition. However, the exact genetic cause remains unknown.

Does blood in the urine always mean cancer?

Hematuria, or blood in the urine, can result from various causes—not just cancer, but also cystitis, bladder stones, and bacterial infections. However, if it recurs, it’s essential to have your pet evaluated by a veterinarian.

How long can my pet be expected to live after treatment?

Reported outcomes vary considerably. One study found a median survival time of about six months (279–385 days) following total cystectomy, while dogs that underwent tumor debulking surgery lived approximately 350 days—longer than those that did not have surgery. Regular follow-up examinations are essential.

Can it be prevented?

While there is no known definitive method of prevention, the most important thing is to catch any abnormalities, such as blood in the urine, early on and detect the condition at an early stage through regular check-ups. Early management can help improve the prognosis.

Is chemotherapy a heavy burden for dogs?

While side effects are possible, your veterinarian will adjust the dosage based on your pet’s weight and condition, so they can usually be managed effectively. Loss of appetite and fatigue may be temporary. The goal of treatment is to manage pain while improving your pet’s quality of life.

Top 5 Recommended Feline Urinary Supplements for 2026 — A Complete Guide to Veterinary Selection Criteria

Top 5 Prescription Diets for Feline FLUTD — Comparison by Struvite and Calcium Oxalate Stones

Top 5 Prescription Urinary Diets for Dogs — Food for Stone Prevention and Management

How to Find a 24-Hour Animal Hospital and Use Emergency Care

What to Prepare for Adopting a Stray Cat — From Pre-Adoption Preparations to New Home Adjustment

The Ultimate Guide to Preparing for Cat Adoption

What to Prepare Before Adopting a Puppy — Essential Checklist

Pet Insurance Comparison and Selection Guide

Pet Health Checkup Timing and Examination Items

How Much Do Veterinary Clinic Fees Cost? A Guide by Category

References

[1] Birchard, S.J., Couto, C.G., & Johnson, S. (1986). Nonlymphoid intestinal neoplasia in 32 dogs and 14 cats. Journal of the American Animal Hospital Association, 22, 533–537.

[2] Knott, J., Simpson, J.W., Tasker, S., et al. (2000). Preliminary clinical observation on the use of piroxicam in the management of rectal tubulopapillary polyps. Journal of Small Animal Practice, 41(9), 393–397.

[3] Moore, A.S., Nelson, R.W., Henry, C.J., et al. (2002). Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989–1999). Journal of the American Veterinary Medical Association, 221, 811–818.